{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:51:16Z","timestamp":1782226276167,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Postgraduate Research & Practice Innovation Program of Harbin Medical University","award":["YJSCX2024-49HYD"],"award-info":[{"award-number":["YJSCX2024-49HYD"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30448-w","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:56:03Z","timestamp":1766076963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["METTL3-mediated m6A modification of TACSTD2 mRNA inhibits papillary thyroid cancer progression by activating the TNF signaling and blocking epithelial\u2013mesenchymal transition"],"prefix":"10.1038","volume":"16","author":[{"given":"Jianting","family":"Man","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiefeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"30448_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E., Jemal, A. & Cancer Statistics,. Cancer Statistics, 2021. CA Cancer J. Clin. 71, 7\u201333. https:\/\/doi.org\/10.3322\/caac.21654 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"30448_CR2","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen, D. W., Lang, B. H. H., McLeod, D. S. A., Newbold, K. & Haymart, M. R. Thyroid cancer. Lancet 401, 1531\u20131544. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X (2023).","journal-title":"Lancet"},{"key":"30448_CR3","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1038\/s41467-020-18497-3","volume":"11","author":"J Yu","year":"2020","unstructured":"Yu, J. et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat. Commun. 11, 4807. https:\/\/doi.org\/10.1038\/s41467-020-18497-3 (2020).","journal-title":"Nat. Commun."},{"key":"30448_CR4","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti, S. et al. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-updagger. Ann. Oncol. 30, 1856\u20131883. https:\/\/doi.org\/10.1093\/annonc\/mdz400 (2019).","journal-title":"Ann. Oncol."},{"key":"30448_CR5","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1210\/jc.2014-3825","volume":"100","author":"D Viola","year":"2015","unstructured":"Viola, D. et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J. Clin. Endocrinol. Metab. 100, 1316\u20131324. https:\/\/doi.org\/10.1210\/jc.2014-3825 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"30448_CR6","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.1073\/pnas.78.8.5147","volume":"78","author":"M Lipinski","year":"1981","unstructured":"Lipinski, M., Parks, D. R., Rouse, R. V. & Herzenberg, L. A. Human trophoblast cell-surface antigens defined by monoclonal antibodies. Proc. Natl. Acad. Sci. U S A. 78, 5147\u20135150. https:\/\/doi.org\/10.1073\/pnas.78.8.5147 (1981).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"30448_CR7","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1073\/pnas.1905384117","volume":"117","author":"EC Hsu","year":"2020","unstructured":"Hsu, E. C. et al. Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1. Proc. Natl. Acad. Sci. U S A. 117, 2032\u20132042. https:\/\/doi.org\/10.1073\/pnas.1905384117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"30448_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1136\/jcp.2008.060590","volume":"62","author":"G Muhlmann","year":"2009","unstructured":"Muhlmann, G. et al. TROP2 expression as prognostic marker for gastric carcinoma. J. Clin. Pathol. 62, 152\u2013158. https:\/\/doi.org\/10.1136\/jcp.2008.060590 (2009).","journal-title":"J. Clin. Pathol."},{"key":"30448_CR9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1369\/0022155411410430","volume":"59","author":"LP Stepan","year":"2011","unstructured":"Stepan, L. P. et al. Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target. J. Histochem. Cytochem. 59, 701\u2013710. https:\/\/doi.org\/10.1369\/0022155411410430 (2011).","journal-title":"J. Histochem. Cytochem."},{"key":"30448_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/onc.2012.36","volume":"32","author":"M Trerotola","year":"2013","unstructured":"Trerotola, M. et al. Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 32, 222\u2013233. https:\/\/doi.org\/10.1038\/onc.2012.36 (2013).","journal-title":"Oncogene"},{"key":"30448_CR11","doi-asserted-by":"publisher","first-page":"100753","DOI":"10.1016\/j.modpat.2025.100753","volume":"38","author":"G Dernbach","year":"2025","unstructured":"Dernbach, G. et al. Spatial expression of HER2, NECTIN4, and TROP-2 in Muscle-Invasive bladder cancer and metastases: implications for pathological and clinical management. Mod. Pathol. 38, 100753. https:\/\/doi.org\/10.1016\/j.modpat.2025.100753 (2025).","journal-title":"Mod. Pathol."},{"key":"30448_CR12","doi-asserted-by":"publisher","first-page":"6136","DOI":"10.18632\/oncotarget.6733","volume":"7","author":"W Zhao","year":"2016","unstructured":"Zhao, W. et al. Trop2 is overexpressed in gastric cancer and predicts poor prognosis. Oncotarget 7, 6136\u20136145. https:\/\/doi.org\/10.18632\/oncotarget.6733 (2016).","journal-title":"Oncotarget"},{"key":"30448_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00384-009-0725-z","volume":"24","author":"YJ Fang","year":"2009","unstructured":"Fang, Y. J. et al. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int. J. Colorectal Dis. 24, 875\u2013884. https:\/\/doi.org\/10.1007\/s00384-009-0725-z (2009).","journal-title":"Int. J. Colorectal Dis."},{"key":"30448_CR14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.ejca.2009.12.019","volume":"46","author":"E Bignotti","year":"2010","unstructured":"Bignotti, E. et al. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. Eur. J. Cancer. 46, 944\u2013953. https:\/\/doi.org\/10.1016\/j.ejca.2009.12.019 (2010).","journal-title":"Eur. J. Cancer"},{"key":"30448_CR15","doi-asserted-by":"publisher","first-page":"e75864","DOI":"10.1371\/journal.pone.0075864","volume":"8","author":"T Liu","year":"2013","unstructured":"Liu, T. et al. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. PLoS One. 8, e75864. https:\/\/doi.org\/10.1371\/journal.pone.0075864 (2013).","journal-title":"PLoS One"},{"key":"30448_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12885-017-3475-2","volume":"17","author":"H Guan","year":"2017","unstructured":"Guan, H. et al. Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways. BMC Cancer. 17, 486. https:\/\/doi.org\/10.1186\/s12885-017-3475-2 (2017).","journal-title":"BMC Cancer"},{"key":"30448_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nature03184","volume":"433","author":"I Blilou","year":"2005","unstructured":"Blilou, I. et al. The PIN auxin efflux facilitator network controls growth and patterning in Arabidopsis roots. Nature 433, 39\u201344. https:\/\/doi.org\/10.1038\/nature03184 (2005).","journal-title":"Nature"},{"key":"30448_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41419-021-03585-z","volume":"12","author":"X Lou","year":"2021","unstructured":"Lou, X., Wang, J. J., Wei, Y. Q. & Sun, J. J. Emerging role of RNA modification N6-methyladenosine in immune evasion. Cell. Death Dis. 12, 300. https:\/\/doi.org\/10.1038\/s41419-021-03585-z (2021).","journal-title":"Cell. Death Dis."},{"key":"30448_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang, X. et al. The role of m6A modification in the biological functions and diseases. Signal. Transduct. Target. Ther. 6, 74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x (2021).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"30448_CR20","doi-asserted-by":"publisher","first-page":"216246","DOI":"10.1016\/j.canlet.2023.216246","volume":"566","author":"C Chen","year":"2023","unstructured":"Chen, C. et al. TROP2 translation mediated by dual m(6)A\/m(7)G RNA modifications promotes bladder cancer development. Cancer Lett. 566, 216246. https:\/\/doi.org\/10.1016\/j.canlet.2023.216246 (2023).","journal-title":"Cancer Lett."},{"key":"30448_CR21","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut 69, 1193\u20131205. https:\/\/doi.org\/10.1136\/gutjnl-2019-319639 (2020).","journal-title":"Gut"},{"key":"30448_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/s41419-020-03071-y","volume":"11","author":"Q Wang","year":"2020","unstructured":"Wang, Q. et al. N(6)-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1\/HK2 modification. Cell. Death Dis. 11, 911. https:\/\/doi.org\/10.1038\/s41419-020-03071-y (2020).","journal-title":"Cell. Death Dis."},{"key":"30448_CR23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1053\/j.gastro.2022.06.024","volume":"163","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. METTL3 inhibits antitumor immunity by targeting m(6)A-BHLHE41-CXCL1\/CXCR2 axis to promote colorectal cancer. Gastroenterology 163, 891\u2013907. https:\/\/doi.org\/10.1053\/j.gastro.2022.06.024 (2022).","journal-title":"Gastroenterology"},{"key":"30448_CR24","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/s41388-022-02185-1","volume":"41","author":"QC Xu","year":"2022","unstructured":"Xu, Q. C. et al. METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m(6)A-YTHDF2-dependent manner. Oncogene 41, 1622\u20131633. https:\/\/doi.org\/10.1038\/s41388-022-02185-1 (2022).","journal-title":"Oncogene"},{"key":"30448_CR25","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","volume":"20","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. m(6)A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat. Cell. Biol. 20, 1074\u20131083. https:\/\/doi.org\/10.1038\/s41556-018-0174-4 (2018).","journal-title":"Nat. Cell. Biol."},{"key":"30448_CR26","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3389\/fonc.2020.01126","volume":"10","author":"Y Shi","year":"2020","unstructured":"Shi, Y. et al. Reduced expression of METTL3 promotes metastasis of Triple-Negative breast cancer by m6A Methylation-Mediated COL3A1 Up-Regulation. Front. Oncol. 10, 1126. https:\/\/doi.org\/10.3389\/fonc.2020.01126 (2020).","journal-title":"Front. Oncol."},{"key":"30448_CR27","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.ymthe.2021.01.019","volume":"29","author":"J He","year":"2021","unstructured":"He, J. et al. METTL3 restrains papillary thyroid cancer progression via m(6)A\/c-Rel\/IL-8-mediated neutrophil infiltration. Mol. Ther. 29, 1821\u20131837. https:\/\/doi.org\/10.1016\/j.ymthe.2021.01.019 (2021).","journal-title":"Mol. Ther."},{"key":"30448_CR28","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41419-022-04817-6","volume":"13","author":"Y Zhu","year":"2022","unstructured":"Zhu, Y. et al. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition. Cell. Death Dis. 13, 358. https:\/\/doi.org\/10.1038\/s41419-022-04817-6 (2022).","journal-title":"Cell. Death Dis."},{"key":"30448_CR29","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"key":"30448_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"30448_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3389\/fcell.2020.00365","volume":"8","author":"JD Webster","year":"2020","unstructured":"Webster, J. D. & Vucic, D. The balance of TNF mediated pathways regulates inflammatory cell death signaling in healthy and diseased tissues. Front. Cell. Dev. Biol. 8, 365. https:\/\/doi.org\/10.3389\/fcell.2020.00365 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"30448_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/1878-0261.12017","volume":"11","author":"KT Yeung","year":"2017","unstructured":"Yeung, K. T. & Yang, J. Epithelial-mesenchymal transition in tumor metastasis. Mol. Oncol. 11, 28\u201339. https:\/\/doi.org\/10.1002\/1878-0261.12017 (2017).","journal-title":"Mol. Oncol."},{"key":"30448_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40364-023-00479-4","volume":"11","author":"L Zhan","year":"2023","unstructured":"Zhan, L. et al. METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer. Biomark. Res. 11, 43. https:\/\/doi.org\/10.1186\/s40364-023-00479-4 (2023).","journal-title":"Biomark. Res."},{"key":"30448_CR34","doi-asserted-by":"publisher","first-page":"139150","DOI":"10.1016\/j.ijbiomac.2024.139150","volume":"291","author":"Y Ding","year":"2025","unstructured":"Ding, Y., Liu, M., Wang, W. & Li, X. YTHDF3-induced degradation of P4HA2 mRNA inhibits Glycolysis in papillary thyroid cancer through Hippo signaling pathway. Int. J. Biol. Macromol. 291, 139150. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.139150 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"30448_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/hep.31220","volume":"73","author":"B Zhou","year":"2021","unstructured":"Zhou, B. et al. N(6) -Methyladenosine reader protein YT521-B homology Domain-Containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes. Hepatology 73, 91\u2013103. https:\/\/doi.org\/10.1002\/hep.31220 (2021).","journal-title":"Hepatology"},{"key":"30448_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2020.03.001","volume":"181","author":"EW Weber","year":"2020","unstructured":"Weber, E. W., Maus, M. V. & Mackall, C. L. The emerging landscape of immune cell therapies. Cell 181, 46\u201362. https:\/\/doi.org\/10.1016\/j.cell.2020.03.001 (2020).","journal-title":"Cell"},{"key":"30448_CR37","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1038\/s43018-021-00282-w","volume":"2","author":"Z Hu","year":"2021","unstructured":"Hu, Z. et al. The cancer surfaceome atlas integrates genomic, functional and drug response data to identify actionable targets. Nat. Cancer. 2, 1406\u20131422. https:\/\/doi.org\/10.1038\/s43018-021-00282-w (2021).","journal-title":"Nat. Cancer"},{"key":"30448_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","volume":"7","author":"Z Fu","year":"2022","unstructured":"Fu, Z., Li, S., Han, S., Shi, C. & Zhang, Y. Antibody drug conjugate: the biological missile for targeted cancer therapy. Signal. Transduct. Target. Ther. 7, 93. https:\/\/doi.org\/10.1038\/s41392-022-00947-7 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"30448_CR39","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/cam4.1934","volume":"8","author":"W Zhao","year":"2019","unstructured":"Zhao, W. et al. The role and molecular mechanism of Trop2 induced epithelial-mesenchymal transition through mediated beta-catenin in gastric cancer. Cancer Med. 8, 1135\u20131147. https:\/\/doi.org\/10.1002\/cam4.1934 (2019).","journal-title":"Cancer Med."},{"key":"30448_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","volume":"572","author":"N Aizarani","year":"2019","unstructured":"Aizarani, N. et al. A human liver cell atlas reveals heterogeneity and epithelial progenitors. Nature 572, 199\u2013204. https:\/\/doi.org\/10.1038\/s41586-019-1373-2 (2019).","journal-title":"Nature"},{"key":"30448_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.18632\/genesandcancer.40","volume":"6","author":"A Shvartsur","year":"2015","unstructured":"Shvartsur, A. & Bonavida, B. Trop2 and its overexpression in cancers: regulation and clinical\/therapeutic implications. Genes Cancer. 6, 84\u2013105. https:\/\/doi.org\/10.18632\/genesandcancer.40 (2015).","journal-title":"Genes Cancer"},{"key":"30448_CR42","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2147\/CMAR.S147033","volume":"9","author":"P Xu","year":"2017","unstructured":"Xu, P. et al. Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas. Cancer Manag Res. 9, 821\u2013837. https:\/\/doi.org\/10.2147\/CMAR.S147033 (2017).","journal-title":"Cancer Manag Res."},{"key":"30448_CR43","doi-asserted-by":"publisher","first-page":"6883","DOI":"10.7150\/jca.62461","volume":"12","author":"H Sun","year":"2021","unstructured":"Sun, H. et al. TROP2 modulates the progression in papillary thyroid carcinoma. J. Cancer. 12, 6883\u20136893. https:\/\/doi.org\/10.7150\/jca.62461 (2021).","journal-title":"J. Cancer"},{"key":"30448_CR44","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1158\/1541-7786.MCR-11-0241","volume":"9","author":"J Wang","year":"2011","unstructured":"Wang, J. et al. Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma. Mol. Cancer Res. 9, 1686\u20131695. https:\/\/doi.org\/10.1158\/1541-7786.MCR-11-0241 (2011).","journal-title":"Mol. Cancer Res."},{"key":"30448_CR45","doi-asserted-by":"publisher","first-page":"e1133","DOI":"10.1038\/cddis.2014.96","volume":"5","author":"F Wang","year":"2014","unstructured":"Wang, F. et al. Loss of TACSTD2 contributed to squamous cell carcinoma progression through attenuating TAp63-dependent apoptosis. Cell. Death Dis. 5, e1133. https:\/\/doi.org\/10.1038\/cddis.2014.96 (2014).","journal-title":"Cell. Death Dis."},{"key":"30448_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1476-4598-9-253","volume":"9","author":"R Cubas","year":"2010","unstructured":"Cubas, R., Zhang, S., Li, M., Chen, C. & Yao, Q. Trop2 expression contributes to tumor pathogenesis by activating the ERK MAPK pathway. Mol. Cancer. 9, 253. https:\/\/doi.org\/10.1186\/1476-4598-9-253 (2010).","journal-title":"Mol. Cancer"},{"key":"30448_CR47","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.3892\/ijmm.2018.3570","volume":"41","author":"W Xi","year":"2018","unstructured":"Xi, W. et al. Incorporation of CD40 ligand enhances the immunogenicity of tumor\u2013associated calcium signal transducer 2 virus\u2013like particles against lung cancer. Int. J. Mol. Med. 41, 3671\u20133679. https:\/\/doi.org\/10.3892\/ijmm.2018.3570 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"30448_CR48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/emmm.201200222","volume":"4","author":"JC Lin","year":"2012","unstructured":"Lin, J. C. et al. TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma. EMBO Mol. Med. 4, 472\u2013485. https:\/\/doi.org\/10.1002\/emmm.201200222 (2012).","journal-title":"EMBO Mol. Med."},{"key":"30448_CR49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40364-021-00278-9","volume":"9","author":"Y Cai","year":"2021","unstructured":"Cai, Y. et al. Novel insights into the m(6)A-RNA methyltransferase METTL3 in cancer. Biomark. Res. 9, 27. https:\/\/doi.org\/10.1186\/s40364-021-00278-9 (2021).","journal-title":"Biomark. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30448-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30448-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30448-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:26:10Z","timestamp":1767788770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30448-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30448"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30448-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"857"}}